Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Supplementation Therapy in Autism and Response to Treatment (START) Study

NCT06187090 is registered in ClinicalTrials.gov with University of Udine as lead sponsor.

NCT NCT06187090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06187090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Supplementation Therapy in Autism and Response to Treatment (START) Study
Lead sponsor
University of Udine
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2023
Completion date
November 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety state, asperger syndrome, autism, autism spectrum disorder, autism spectrum disorder high-functioning, depressive symptoms